San Francisco-based private equity firm Genstar Capital LLC has completed its $797 milion acquisition of PRA International, a global clinical research organization based in North Carolina, the company announced today.
Shareholders approved the acquisition Wednesday and will receive $30.50 per share of common stock in cash. PRA stock will be delisted from Nasdaq at the close of the  markets.
Department has completed about 10 percent of federal recommendations for improvement
In August, Mayor London Breed and traffic safety watchers blasted San Francisco… Continue reading
PG&E has accepted an offer of technical assistance and aircraft to help… Continue reading
Sparks near the transbay tube prompted BART to halt some service between… Continue reading
When BART board director Debora Allen first floated her proposal to ban… Continue reading
